Abstract
Blenderized tube feeding (BTF), defined as tube feeding substrate derived from whole food, has demonstrated clinical utility to reduce tube feeding intolerance, achieve a physiologic diet, and bridge to oral feeding. BTF use peaked in the 1950s but was displaced by commercial formula (CF) in subsequent decades, as the latter has a consistent nutrient content, is sterile, and is less likely to clog tubes. Interest and use of BTF have reemerged and are largely driven by patients or caregivers reporting improved tolerance to whole-food blends compared with CF. BTF may have additional clinical applications, including preparation for radioactive iodine (RAI) ablation. This article presents a case of an adult male patient with thyroid cancer who utilized BTF to achieve the iodine status needed for effective RAI treatment.